four Sugiyama et al., 1987) serotypes. The primary aim of the present study was to analyse the antigenic relationship between hantaviruses at the viral polypeptide level using a radioimmunoprecipitation assay (RIPA) and sera from different sources.
The history of the hantavirus strains examined is summarized in Table 1 . All strains were propagated in Vero E6 cells (CTL 1586; American Type Culture Collection) maintained in Eagle's MEM supplemented with 2~ foetal bovine serum. The two envelope glycoproteins G1 and G2 and the N protein could be readily identified in RIPA for all strains examined (Fig. 1) . The L protein could not be efficiently immunoprecipitated and was therefore not considered further in this study. No major Mr differences in the G1 (72K to 74K) and G2 (55K to 57K) glycoproteins were seen between the strains examined. However, the N protein of strains 76-118, 80-39 and 4605 had an Mr of 50K, whereas that of strains 83-223L, CG-13891, CG-1820 and K-27 was 54K.
Radiolabelled virus antigens for RIPA analyses were prepared for strains 80-39, 76-118 and 4605 as described in the legend to Fig. 1 . For strains 83-233L, CG-1820, CG-13891 and K-27, the similar migration distance of the G2 and N proteins following SDS-PAGE made their analysis by immunoprecipitation difficult. Consequently, the antigens for these strains were processed to a glycoprotein-and a nucleocapsid-enriched fraction, and each serum was then simultaneously tested against both fractions. The enriched antigen fractions were prepared as follows. Pelleted radiolabelled virus prepared as described for Fig. 1 was resuspended in RIPA buffer without KC1 and the suspension was kept at 4 °C for 1 h and centrifuged at 14000 g for 30 min. The supernatant was divided into equal portions and each was layered onto a double sucrose cushion consisting of 0.15 ml 60~ (w/w) sucrose with 0.65 ml 15~ (w/w) sucrose on the top. Samples were spun in an SW60 rotor. For the glycoprotein fraction, centrifugation was performed at 50000 r.p.m, for 175 min. The supernatant above the sucrose cushion was retained and made to 0.7 M with solid KC1. For the nucleocapsid-enriched fraction, centrifugation was performed at 50000 r.p.m, for 135 min. The supernatant was removed and the sucrose fraction made up to the same volume as the glycoprotein fraction with RIPA buffer without KC1 and finally to 0.7 M with solid KC1.
The available HFRS patient sera had been collected at different time intervals from the onset of symptoms. Therefore before cross-strain analyses, the sera were tested in RIPA with their 'homologous' antigens. For comparison, the sera were also titrated by IFT using acetone-fixed virus-infected cells as previously described (Niklasson et al., 1983) . Analyses of triplicate sera (acute, early convalescent and late convalescent phase) from 10 Swedish patients were carried out using the 'homologous' 83-223L strain antigen. Most of the acute phase sera, although showing high titres in IFT, only precipitated the N protein. The early convalescent phase sera precipitated the N protein, but the G1 and G2 proteins were only poorly precipitated, whereas the late convalescent phase sera strongly precipitated all three viral proteins. RIPA analysis of ; bovine serum albumin, 69000; ovalbumin, 46000; carbonic anhydrase, 30000. RIPA antigen was prepared as follows. Fourteen days post-infection, virus-infected Vero E6 cells (150 cm 2 confluent monolayer) were incubated with Eagle's MEM containing actinomycin D (10 Bg/ml) for 3 h at 37 °C. The cell monolayer was then washed with phosphate-buffered saline, then 20 ml of Eagle's MEM containing one-tenth the normal concentration of methionine, 1 mCi [3SS]methionine, 2~o foetal bovine serum and 10 ~tg/ml actinomycin D were added, and the cells were re-incubated at 37 °C for 36 h. The supernatant was removed, clarified, and the virus pelleted by centrifugation at 85 000 g for 75 min. The virus pellet was resuspended in 3 ml RIPA buffer (2~o Triton X-100, 0.7 M-KCI, 0.15 M-NaCI, 0-3 trypsin inhibitor units per ml aprotinin, 0.01 M-Tris-HCI pH 7.8) and sonicated. The suspension was kept at 4°C for 1 h and centrifuged at 14000g for 30 min. The supernatant was used for immunoprecipitation. RIPA and SDS-PAGE on 12-5% (37 : 1 acrylamide : bisacrylamide) gels were performed as described (Sheshberadaran & Norrby, 1986) . In all RIPAs, 0.75 ml radiolabelled antigen and 2 ~tl undiluted antibody were used per sample.
six Korean patient sera (five early and one late convalescent phase) using the 'homologous' 76-118 strain gave similar results. The five early convalescent phase sera precipitated only the N protein, while the late convalescent phase serum precipitated the G1 and G2 proteins also. Similar data were obtained for the U.S.S.R. H F R S patient sera (16 sera from European U.S.S.R. and 11 sera from Asian U.S.S.R. were tested). The difference in the capacity of sera from different phases of the disease to immunoprecipitate the viral glycoproteins may have arisen partly from changes in the antigenic specificity of the immune response and partly from the inability of Protein A used in the R I P A to bind efficiently to all human IgG subclasses. For cross-strain analyses, late convalescent phase sera were preferentially selected. HFRS is endemic in a belt from Norway in the west, through Sweden, Finland, U.S.S.R., China and Korea to Japan in the east. The clinical severity of HFRS varies in this belt. A severe form of the disease with haemorrhagic manifestations and significant mortality occurs in Korea (KHF). The clinical form of the disease found in Scandinavia and Finland [commonly called nephropathia epidemica (NE)] is milder, with no significant haemorrhagic manifestations, and very low or no mortality. In the U.S.S.R. both clinical forms are present, with the Ural mountains seemingly forming a border between the Asian severe and the European more benign 
Reactivity of HFRS patient sera with hantavirus strains in IFT* and RIPA~
Virus strain ~f RIPA reactivity is expressed as: +, distinct; +w, weak; -, none for the viral G1, G2 and N proteins. :~ RIPA reactivity was the same as shown for strain 83-223L. § RIPA reactivity was the same as shown for strain 76-118. IJ All sera were late convalescent (2 months up to > 2 years) except for European U.S.S.R. patient 3258 serum which was taken 16 days after onset of the disease. ¶ A very weak immunoprecipitation of the N protein was seen. 
Reactivity of animal immune sera with hantavirus strains in IFT* and RIPA~
Virus strain II Rabbit immune serum was prepared using affinity bead immunization (Johansson et al., 1979) . A high titre late convalescent human serum was bound to CNBractivated Sepharose 4B beads (Pharmacia) and the beads were mixed with supernatant medium from 83-223L-infected Veto E6 ceils. The medium was collected 14 days post-infection and clarified of cell debris before immunoadsorption of the extraceilular virus antigen. The preparation was washed, mixed with an equal volume of complete Freund's adjuvant and aliquots were administered twice intramuscularly at 6 week intervals. Serum was collected 9 weeks after the first injection.
Immunoglobulin was prepared by ammonium sulphate fractionation. Anti-human ]g-reactive antibodies were eliminated by affinity chromatography (Niklasson et al., 1984) . ¶ Rabbit immune sera to strains 76-118 and 80-39 were prepared using a single dose injection of purified Vero E6-grown virus. Sera were collected 8 weeks postinoculation. These sera were kindly provided by Dr J. W. LeDuc, USAMRIID, Frederick, Md., U.S.A.
** Two
Clethrionomys glareolii were infected in the laboratory with strain 83-223L and sera were collected 60 days post-infection.
"J't Icr, Not tested.
bo ~D
Short communication
form. The virus strains and sera tested in this study were selected to include both major clinical forms of HFRS found in this geographical belt (see Table l ).
The cross-strain RIPA data with the selected HFRS patient sera are shown in Table 2 and exemplified in Fig. 1 . The cross-IFT data for the same sera are also included in Table 2 . In terms of the overall degree of cross-reactivity, the IFT and RIPA data always matched. The seven hantavirus isolates tested fell into three distinct antigenic groups. (i) The NE-type consisted of isolates 83-223L (Swedish), CG-13891 (Belgian), CG-1820 and K-27 (European U.S.S.R.). All these isolates exhibited the same patterns of reactivity; their N, G1 and G2 proteins were strongly immunoprecipitated by the Swedish NE patient and the European U.S.S.R. patient sera. RIPAs of these strains using the Asian U.S.S.R. and Korean sera were essentially negative.
(ii) The KHF-type group consisted of the 76-118 (Korean) and the 4605 (Asian U.S.S.R.) isolates. These two isolates were seen to be antigenically very closely related to each other but distinct from the NE-type isolates. A one-way cross-reaction was seen by both IFT and RIPA between the KHF-type and the NE-type isolates. Whereas the KHF-type patient immune sera failed to react with the NE-type virus proteins, the KHF-type virus isolates' N protein was distinctly, and the G1 and G2 proteins were weakly, immunoprecipitated by the NE-type patient sera. Off) The third antigenic group consisted of the only rat isolate tested, the urban rat isolate . This appeared to be antigenically related in all three viral proteins with both the other two antigenic groups. However, its pattern of reactivity with the different patient sera indicated that it was distinct from isolates of either of the two groups.
To extend the antigenic analyses with HFRS human sera, cross-RIPA and cross-IFT were performed using animal immune sera (Table 3 , Fig. 1 ). The three antigenic groupings seen in cross-analyses with patient sera were also seen with the animal sera. The cross-analyses with the animal immune sera clearly indicate that between the three antigenic groups the major crossreactive antigen is the N protein. Of the two glycoproteins, the G2 protein was weakly crossreactive between the groups, while the G1 protein appeared to be the least cross-reactive. In a recent study using monoclonal antibodies raised against the G1 and G2 proteins of a Japanese hantavirus (Dantas et al., 1986) it was seen that both glycoproteins carried neutralizing epitopes. In cross-NTs with the 76-118 strain, only some of the anti-G2 monoclonal antibodies crossreacted. Taken together with our data, it appears that the G2 glycoprotein carries both groupcross-reactive and group-specific epitopes, while the G I glycoprotein carries mainly groupspecific epitopes. The data obtained with the animal immune sera also highlight certain hostspecific features of hantavirus serology. A one-way cross-reaction was seen between the NEtype antigenic group and the KHF-type antigenic group when using patient sera; however, with rabbit immune sera, a reciprocal cross-reaction was clearly seen between these two groups of isolates in both RIPA and IFT. Another possible host species response difference was seen with the urban rat isolate. The G 1 of this isolate was not precipitated by the rabbit anti-83-223L virus serum but was strongly precipitated by the Swedish NE patient sera (see Fig. 1 ).
The data presented in this study clearly indicate that the HFRS in the U.S.S.R. falls into two distinct antigenic groups: European U.S.S.R. HFRS which bears a close antigenic relationship to the Belgian and Swedish NE, and Asian U.S.S.R. HFRS which is closely related to the Korean KHF. This antigenic grouping matches the clinical grouping of the HFRS in the respective regions, i.e. a severe compared to a milder clinical form of the disease. However, a cross-neutralization test is necessary for definitive serological grouping of these viruses. Importantly, it remains to be determined in what way these antigenic differences are related to the pathogenic differences between the viruses.
